Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Perrigo Expanding Consumer Portfolio After Finding Problems Slowing Growth

Jan 15 2019

• By Malcolm Spicer

Pros and cons concept. Business man with cardboard plus and minus symbol signs.

Related Content

Inversion Crackdown: Does It Spell The End For Pfizer/AstraZeneca?

Sep 24 2014

Perrigo’s Irish Move Sets Stage For International Boost, Net Revenue Gain

Aug 02 2013

Perrigo Pivots To 'Self Care' For 'Massive Opportunity' Beyond OTC Drugs

Nov 10 2018

Irish $1.9bn Tax Bill 'Out Of Nowhere' Perplexes Perrigo, Troubles Analysts

Jan 15 2019

Amazon OTCs Likely A Worry For Retailers, A Remedy For Perrigo

Jan 09 2018

Related Companies

Perrigo Company PLC

Elan Corporation

Omega Pharma NV

Viatris Inc.

Additional Topics

International Europe United States Commercial OTC Drugs Dietary Supplements Advertising, Marketing & Sales Business Strategies Deals M & A Strategy C-Suite Speaks Consumer

More from Business

More from Wellness

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window